Candel Therapeutics (NASDAQ:CADL) Issues Quarterly Earnings Results, Misses Expectations By $0.30 EPS
Candel Therapeutics (NASDAQ:CADL – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.54) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.30), FiscalAI reports. Candel Therapeutics Trading Down 0.6% CADL traded down $0.03 during trading on Thursday, hitting $5.07. 437,324 shares of the stock […]
12 Mar 11:36 · The Cerbat Gem